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Abstract
Background:  The  Quality  of  Life  Scale  (QLS)  was  developed  to  assess  the  quality  of  life  of
patients with  schizophrenia,  by  Heinrichs,  Hanlon  and  Carpenter,  in  1984.
Objectives:  This  systematic  review  analysed  the  scientiﬁc  evidence  produced  from  the  QLS
results and  its  relationship  with  the  symptomatology  of  patients  with  schizophrenia.
Methods:  An  electronic  search  was  conducted  on  Pubmed/Medline  and  Scopus  to  identify  rele-
vant papers  published  within  the  last  ten  years  (January  2007  to  December  2016).  The  inclusion
criteria were:  studies  whose  samples  included  only  outpatients  with  schizophrenia;  studies
whose aim  was  to  compare  the  QLS  results  with  the  symptomatology  of  schizophrenia;  studies
written in  English.  The  PRISMA  criteria  for  reporting  systematic  reviews  and  meta-analyses  were
used.
Results: Twelve  studies  were  included  in  this  systematic  review.  A  total  of  1645  patients  with
schizophrenia  from  four  different  countries  were  analysed.  Ten  articles  used  a  cross-sectional
study methodology  and  2  articles  involved  a  longitudinal  study.
Conclusions:  Synthesis  suggests  that  quality  of  life/functioning  in  patients  with  schizophrenia
can be  inﬂuenced  by  negative  symptoms.  Nevertheless,  in  relation  to  positive  and  depres-
sive symptoms,  the  results  are  not  congruent  nor  consistent.  Therefore,  this  literature  review
indicated that  more  research  is  needed  in  order  to  obtain  better  evidence  with  regards  to  the
inﬂuence of  that  symptomatology  on  the  quality  of  life/functioning  in  patients  with  schizophre-
nia.
© 2017  Asociacio´n  Universitaria  de  Zaragoza  para  el  Progreso  de  la  Psiquiatr´ıa  y  la  Salud  Mental.
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7-item  scale.  Another  study  validated  a  QLS  5-item  scale.
In  2016  the  QLS  was  revised  using  exploratory  factor  anal-
yses  and  conﬁrmatory  factor  analyses  to  assess  the  factor
structure  of  the  QLS.  The  sample  was  comprised  of  two
b PRISMA Transparency reporting of systematic reviews and
meta-analyses. Available in PRISMA Transparency reporting
of systematic reviews and meta-analyses. Available from:
http://www.prisma-statement.org/ [cited 30.1.17]. 
ntroduction
chizophrenia  is  a  severe  mental  disorder  characterised
y  delusions,  hallucinations,  disorganised  speech,  grossly
isorganised  or  abnormal  motor  behavior  and  negative
ymptoms.  In  most  cases  still  appear  cognitive  impair-
ents  and  affective  symptoms.  This  pathology  is  associated
ith  signiﬁcant  social  and  occupational  dysfunctions.1 These
eﬁcits  are  present  in  over  60%  of  patients  with  schizophre-
ia  and  normally  arise  during  the  ﬁrst  ﬁve  years  of
he  disease’s  progression.2 The  best  predictors  of  the
eterioration  of  social  functioning  seem  to  be  negative
ymptoms.3
The  symptoms  of  this  mental  illness  are  associated  with
conomic,  professional,  social  and  functional  difﬁculties
n  patients  who  have  long  hospitalisation  periods,  delayed
ecovery  and  poor  treatment  outcomes,  which  considerably
amage  their  quality  of  life.4
For  all  these  reasons,  patients  with  schizophrenia
ave  a  poor  quality  of  life  as  indicated  in  several
tudies.5--10 Most  of  the  recent  studies  related  to  the  rela-
ionship  between  quality  of  life  and  the  symptoms  of
chizophrenia  indicate  that  negative  and  positive  symp-
oms,  as  well  as  depression  and  anxiety,  are  related  to
 lower  quality  of  life.5,8,11--14 Other  studies  delve  into
he  relationship  between  quality  of  life  and  socio  demo-
raphic  characteristics,  including  age,  employment  and  life
onditions.6,9,14,15
There  are  many  scales  to  evaluate  the  quality  of  life,
ut  not  all  are  appropriate  for  mental  illness.  The  Qual-
ty  of  Life  Scale  (QLS)  was  developed  by  Heinrichs,  Hanlon
nd  Carpenter,  in  1984,  to  assess  the  quality  of  life  of
atients  with  schizophrenia.16 The  QLS  has  been  an  impor-
ant  assessment  instrument  in  a  great  deal  of  research.  In  a
eview  of  quality  of  life  scales  used  in  studies  investigating
he  quality  of  life  in  patients  with  schizophrenia  conducted
rom  January  2009  to  December  2013,  the  results  demon-
trate  that  the  most  widely  used  schizophrenia-speciﬁc
uality  of  life  scale  was  QLS.17 In  addition  to  assessing
he  quality  of  life,  the  QLS  is  recurrently  used  to  assess
unctional  outcomes  in  schizophrenia18 and  is  the  most
idely  used  scale  in  research  on  assessing  functioning.19
he  QLS  stands  out  from  the  other  scales  as  it  measures
he  functioning  of  patients  with  schizophrenia  and  con-
iders  negative  symptoms,  regardless  of  the  presence  or
bsence  of  positive  symptoms.  This  instrument  assesses
ersonal  experience,  the  quality  of  personal  relationships
nd  productivity  in  their  occupational  role.16 Moreover,
he  QLS  has  been  validated  in  a  number  of  countries
ncluding  the  United  States,  France,  Portugal,  Spain,
razil  and  India,  with  good  psychometric  qualities  in  all
alidation  studies.16,20--24 For  all  of  these  reasons,  in  this
eview,  we  chose  to  assess  manuscripts  which  had  used  the
LS.
The  aim  of  this  study  is  to  analyse  the  scientiﬁc  evidence
roduced  from  the  QLS  results  and  its  relationship  with  the
ymptomatology  of  patients  with  schizophrenia.L.M.G.  de  Pinho  et  al.
ethod
ata  sources  and  searches
he  PRISMA  criteria  were  applied  for  meta-analyses  and
ystematic  reviews  (Prisma).b The  EndNote  bibliographic
omputer  program  was  used  in  this  study.
We  conducted  a  study  of  the  literature  review  using  digi-
al  database  research,  Medline/Pubmed,  and  Scopus,  in  the
ast  ten  years  (2007  to  2016).  We  recognised  articles  pub-
ished  in  international  journals  which  used  the  QLS.  The
escriptors  ‘‘schizophrenia  AND  QLS’’  were  used.  Our  search
as  restricted  to  articles  published  in  English.
uality  of  Life  Scale  (QLS)
 Quality  of  Life  Scale  (QLS)  was  developed  in  1984  by  Hein-
ichs,  Hanlon  and  Carpenter.  Its  initial  purpose  to  measure
he  deﬁcit  syndrome  in  patients  with  schizophrenia  within
he  last  four  weeks.  It  consists  of  a  semi-structured  21-
tem  interview  with  7  points  for  each  item.  It  should  be
pplied  by  a  clinician  and  takes  approximately  45  minutes
o  be  applied.  It  is  divided  into  four  dimensions:  Intrapsy-
hic  Foundations  --  IF  (which  assesses  motivation,  curiosity,
mpathy,  the  ability  to  feel  pleasure  and  emotional  inter-
ction);  Interpersonal  Relations  --  IR  (which  assesses  the
uality  and  quantity  of  social  relationships);  Instrumen-
al  Role  Functioning  --  IRF  (which  assesses  productivity  in
heir  occupational  role,  whether  at  work,  at  school  or  in
ousehold  chores/parental  role)  and  Common  Objects  and
ctivities  --  COA  (which  assesses  the  possession  of  common
bjects,  such  as  a  watch  to  see  the  time  and  involvement  in
egular  activities  which  assume  active  participation  in  soci-
ty,  such  as  using  public  transport).  The  total  score  of  the
cale  and  each  of  the  domains  ranges  from  0  to  6.  A  score
etween  5  and  6  is  considered  unaltered,  from  2  to  4  reveals
onsiderable  loss,  and  a  score  between  0  and  1  suggests
erious  impairment  in  functioning.
Subsequently,  abbreviated  versions  of  the  scale  which
emonstrated  good  psychometric  properties  were  con-
tructed  to  facilitate  their  application  in  clinical
ettings.25--27 In  one  of  the  studies,  the  results  showed
hat  an  abbreviated  version  of  the  7-item  scale  predicted
 total  score  of  21  items  with  high  precision,  obtaining
eliable  results.25 Recently,  another  study  validated  these
esults,  using  a  sample  of  1430  participants,  for  the  same
27
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groups,  a  mixed  diagnostic  sample  of  multi-episode  par-
ticipants  (N  =  247)  and  a  sample  of  individuals  with  a  ﬁrst
psychotic  episode  (N  =  337).  The  results  showed  the  strength
of  the  3-factor  model  of  the  QLS-R  in  schizophrenia  and
mixed  diagnostic  samples.18
Eligible  criteria
All  of  the  articles  were  evaluated  according  to  the  following
criteria:  (1)  the  study  samples  include  only  outpatients  with
schizophrenia;  (2)  the  aim  of  the  studies  was  to  compare
the  QLS  results  with  the  symptomatology  of  schizophrenia;
(3)  studies  written  in  English.  The  inclusion  and  exclusion
criteria  are  described  in  Table  1.  Studies  that  did  not  meet
the  above  criteria  were  excluded.
Data  extraction
Pertinent  data  were  extracted  by  two  reviewers  indepen-
dently  and  divergences  were  resolved  by  discussion  and  new
analyses  of  the  article.  Whenever  necessary,  a  third  reviewer
was  consulted.  The  studies  were  compiled  in  a  summary
table  for  a  better  understanding  of  the  systematic  liter-
ature  review.  This  table  was  compiled  under  nine  items:
author,  year,  sample,  country,  methodology,  instruments,
dimensions  evaluated,  results  and  aim  of  the  studies  review
(Table  2).
Selection  process
In  the  ﬁrst  search,  when  the  descriptors  ‘‘QLS  AND
schizophrenia’’  were  used,  we  found  79  articles  published
in  Medline/PubMed  and  91  published  in  Scopus.  A  number
of  the  same  scientiﬁc  papers  had  been  published  in  both
databases.  Nevertheless,  we  found  15  different  publications
in  Scopus,  so  that  there  were  94  publications  to  analyse  in
all.
89  full-text  publications  were  analysed  and  77  were
excluded:  12  articles  were  related  to  patients  living  in
institutions  or  patients  with  other  pathologies  associated
with  schizophrenia;  56  publications  did  not  compare  the
QLS  results  with  the  symptomatology  of  schizophrenia  (27
publications  were  concerned  with  medication  or  treatment
in  schizophrenia,  2  publications  focused  on  the  abbrevi-
ated  QLS  scale,  1  publication  dealt  with  conﬁrmatory  factor
analysis  of  the  QLS,  6  articles  were  about  the  psychometric
characteristics  of  other  scales;  and  20  publications  had  an
another  aim),  5  articles  had  not  been  written  in  English  and
4  articles  were  not  primary  studies.
In  all,  12  studies  were  included  in  this  review.  The  study
selection  process  is  shown  in  the  following  ﬂowchart  (Fig.  1).
Results
Twelve  complete  articles  which  met  the  criteria  were  ana-
lysed  and  used  in  this  review  (Table  2).  A  total  of  1645
patients  with  schizophrenia  (1023  males  and  622  females)
from  four  different  countries  (Brazil,  Italy,  United  States,
Japan)  were  also  analysed.
All  of  the  studies  used  internationally  recognised  diag-
nostic  criteria  for  schizophrenia  with  10  studies  using
p
n
w
tnts  3
he  Diagnostic  and  Statistical  Manual  of  Mental  Disorders
DSM  IV-TR  or  DSM-IV),  1  article  using  the  International
lassiﬁcation  of  Diseases  (ICD-10)  and  one  study  apply-
ng  the  Mini  International  Neuropsychiatric  Interview  (MINI)
o  conﬁrm  diagnoses.  All  of  the  samples  were  made  up
f  patients  at  a  stable  stage  of  the  disease  in  outpatient
reatment.
Ten  articles  were  stemmed  from  cross-sectional  studies
hile  2  articles  were  based  on  longitudinal  studies.
Data  collection  of  all  of  the  studies  was  carried  out  in
ealth  institutions,  such  as  departments  of  psychiatry  or
sychosocial  rehabilitation  centres  and  adhered  to  ethical
rinciples,  with  permission  obtained  from  ethics  committees
nd  from  the  institutions  where  the  studies  were  conducted.
articipants’  informed  consent  was  also  obtained  in  all  of
he  studies.  The  assessment  instruments  were  applied  by
xperienced  researchers.
All  of  the  studies  evaluated  psychotic  symptoms  which
re  characteristic  of  schizophrenia  (negative  symptoms  and
ositive  symptoms).  To  evaluate  these  symptoms,  10  studies
sed  the  Positive  and  Negative  Syndrome  Scale  (PANSS),  one
tudy  used  the  Scale  for  Assessment  of  Negative  Symptoms
SANS)  and  the  Scale  for  Assessment  of  Positive  Symptoms
SAPS)  and  a  study  used  the  Brief  Psychiatric  Rating  Scale
BPRS).
With  respect  to  negative  symptoms,  PANSS  evaluates  the
resence  and  degree  of  blunted  affect,  emotional  with-
rawal,  poor  rapport,  passive/apathetic  social  withdrawal,
ifﬁculty  in  abstract  thinking,  lack  of  spontaneity  and  ﬂow
f  conversation  and  stereotyped  thinking.  Regarding  positive
ymptoms,  it  evaluates  the  presence  and  degree  of  delu-
ions,  conceptual  disorganisation,  hallucinatory  behavior,
xcitement,  grandiosity,  suspiciousness/persecution,  and
ostility.
Seven  studies  also  evaluated  depressive  symptomatology.
hey  all  used  the  Calgary  Depression  Scale  for  Schizophre-
ia  (CDSS),  which  has  been  specially  developed  to  evaluate
epressive  symptoms  in  patients  with  schizophrenia,  dis-
inguishing  it  from  psychotic  symptoms  and  side  effects  of
ntipsychotics.
One  study  evaluated  the  basic  symptoms  assessed  by
he  Italian  version  of  the  Frankfurt  Complaint  Questionnaire
FCQ),  called  FBF,  evaluating:  loss  of  control,  simple  per-
eption,  complex  perception,  language,  thought,  memory,
otility,  lack  of  automatism,  anhedonia,  anxiety  and  sen-
ory  overstimulation.
Regarding  the  aims  of  the  studies,  8  had  stated  that
ne  of  their  speciﬁc  aims  was  to  evaluate  the  relation-
hip  between  quality  of  life/functioning  assessed  through
he  QLS  and  the  symptomatology.  One  of  these  only
ssessed  the  symptom  disorganisation  and  4  speciﬁcally
ssessed  the  clinical  factors,  including  symptomatology,
nd  quality  of  life/functioning.  Of  these  studies,  four  also
valuated  cognitive  dysfunction;  one  evaluated  insight  and
oping,  one  assessed  levels  of  life  skills  and  one  self-
erceived  recovery.  Two  also  studied  sociodemographic
ata.
In  one  study,28 the  results  demonstrated  that  the  best
redictors  of  quality  of  life  are  negative  symptoms  and  cog-
itive  deﬁcits.  Better  QLS  results  were  found  in  patients
ith  fewer  negative  symptoms  regardless  of  the  results  of
he  Schizophrenia  Cognition  Rating  Scale  (SCoRS).  Moreover,
4  L.M.G.  de  Pinho  et  al.
Table  1  Inclusion/exclusion  criteria.
Inclusion  criteria  Exclusion  criteria  Justiﬁcation  of  criteria
Studies  in  with  the
sample  only  included
outpatients  with
schizophrenia
The  sample  of  the  studies
which  included  patients  with
other  pathologies  associated  or
patients  living  in  institutions
We  included  only  studies  that  examine
outpatients  with  schizophrenia  and  excluded
studies  that  analysed  patients  living  in  institutions
or patients  with  other  pathologies,  for  example,
schizophreniform  disorder,  delusional  disorder  or
ﬁrst psychotic  episode
The aim  of  the  studies
was  to  compare  the
results  of  the  QLS  with
symptomatology  of
schizophrenia
Publications  that  did  not
compare  the  results  of  QLS
with  the  symptomatology  of
schizophrenia
We  excluded  publications  that:
compare  the  results  of  QLS  with  medication  or
other  types  of  treatment;
compare  the  results  of  the  QLS  with  cognitive
impairments;
evaluated  the  psychometric  characteristics  of  the
QLS  or  other  scales;
compare  a  patient-rated  subjective  QoL  scale
with  an  observer-rated  QoL  scale;
and
other  articles  that  did  not  compare  the  results  of
the QLS  with  the  symptomatology  of  schizophrenia
Studies written  in  English  Studies  not  written  in  English  Only  studies  written  in  English  were  included
Primary studies  Books  chapters,  conference
abstracts;  commentaries;
reviews;  dissertations.
Studies  were  restricted  to  primary  studies  with
empirical  literature
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Table  2  Summary  of  information  from  seventeen  relevant  articles  which  met  our  inclusion  criteria  in  the  study  of  ‘‘Quality  of  Life  in  Patients  with  Schizophrenia  evaluated
with the  Quality  of  Life  Scale  (QLS)’’.
Author/year  Sample  Country  Methodology  Instruments  Dimensions  evaluated Aim  Results
Cruz  et  al.,
201628
N  =  79  outpatients
with  schizophrenia
(MINI  criteria)
Brazil  Cross-sectional
study
QLS-BR
SCoRS
PANSS
CDSS
Quality  of  life
Cognition
Severity  of  symptoms
To  evaluate  the
correlation
between  QOL,
symptoms  and
cognition.
The  best  predictors  of  quality  of  life  (QOL)
were  cognitive  deﬁcits  (p  <  0.001)  and  negative
symptoms  (p  <  0.001).  Regardless,  positive
symptoms  also  inﬂuence  quality  of  life
(p =  0.026).
A  better  QOL  was  found  in  patients  with  a  low
degree of  negative  symptoms,  regardless  of
SCoRS  rating.  Between  participants  with  more
severe  negative  symptoms,  a  worse  QOL  was
found  in  patients  with  elevated  cognitive
impairment.
Rocca et  al.,
201629
N  =  323  outpatients
with  schizophrenia
(DSM-IV-TR)
Italy  Cross-sectional
study
QLS
PANSS
CGI-S
CDSS
GAF
SUMD
Quality  of  life
Symptoms
Levels  of  functioning
To  identify  proﬁles
of  functioning  in
patients  with
schizophrenia
empirically;
To  assess  factors
associated  with
the  best  proﬁle
membership.
The  results  demonstrate  that  fewer  negative
symptoms,  less  severe  depressive  symptoms,
being employed,  having  a  long-term
relationship,  and  treatment  with  SGAs  were
associated  with  good  functioning.
Montemagni
et al.,  201430
N  =  92  outpatients
with  schizophrenia
(DSM-IV-TR)
Italy  Cross-sectional
study
QLS
CGI-S
PANSS
CDSS
GAF
SUMD
WCST
RSES
CISS
Quality  of  life
Global  illness  severity
Negative  symptoms
Insight
Coping
To  assess  the
relative  inﬂuences
of  negative
symptomatology,
insight  and  coping
on  QOL.
The  results  suggest  that  for  patients  with
higher  negative  symptoms,  insight  and
coping-social  diversion  contribute  to  QOL:
higher  negative  symptoms  predict  worse
intrapsychic  foundations  (QLS-IF)  subscale
scores  and  symptoms  and  coping-social
diversion  suggest  a  positive  QLS-IF.
Kukla et  al.,
201431
N  =  68  outpatients
with  schizophrenia
(DSM-IV-TR)
United
States
Cross-sectional
study
QLS
PANSS
RAS
Quality  of  life
Perceptions  of
recovery
Symptomatology
To  evaluate  the
relationship
between
self-perceived
recovery,
symptoms,  and  the
social  components
of  quality  of  life.
The  results  demonstrate  that  the  participants
with  more  severe  levels  of  positive  symptoms
and a  stronger  subjective  recovery  achieved
higher  levels  in  the  QLS  Intrapsychic
Foundations  and  the  QLS  instrumental  role
functioning  compared  to  participants  with  high
positive  symptoms  but  lower  levels  of  recovery.
6
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Table  2  (Continued)
Author/year  Sample  Country  Methodology  Instruments  Dimensions  evaluated  Aim  Results
Rocca  et  al.,
201432
N  =  92  outpatients
with  schizophrenia
(DSM-IV-TR)
Italy  Cross-sectional
study
QLS
PSP
CDSS
CGI-S
SANS
SAPS
Real-world
functioning
Negative  symptoms
(DE  --  affective
ﬂattening  and  alogia;
AA  --  avolition  and
anhedonia)
To  assess  the
relationship  of
speciﬁc  negative
symptoms’
components  (DE,
AA) with  separate
domains  of  real
world  outcomes
(the  PSP  and
selected  items  of
the  QLS)  and
recent
employment  and
marriage.
AA  was  associated  with  the  level  of  the  QLS
interpersonal  relations  and  social  network,  and
the  personal  and  social  performance  measured
by the  PSP.
The  AA  subdomain  was  a  signiﬁcant  predictor
of  the  social  outcome,  marriage.
The  DE  subdomain  does  not  appear  to  have  an
impact  on  real-world  functional  performance.
Sigaudo et  al.,
2014
N  =  276  outpatients
with  schizophrenia
(DSM-IV-TR)
Italy  Cross-sectional
study
QLS
CGI-S
PANSS
Stroop  Test
TMT
CVLT
WCST
Quality  of  life
Disorganisation
Cognitive  dysfunction
To  evaluate  the
relative
contributions  of
disorganisation
and  cognitive
dysfunction  to
QOL.
Disorganisation  had  a  negative  relationship
with  QOL,  with  the  role-functioning  domain
and  the  intrapsychic  functioning  domain.
Verbal  memory  was  a  partial  moderator  of  the
association  between  disorganisation  and  QOL.
Silva et  al.,
201134
N  =  79  outpatients
with  schizophrenia
(ICD-10)
Brazil  Cross-sectional
study
QLS-BR
PANSS
Quality  of  life
Social-demographic
factors
Clinical  factors
To  assess  QOL  and
the
sociodemographic
and  associated
clinical  factors  in
patients  with
schizophrenia.
Occupational  performance  was  the  most
frequently  affected  area.  Marital  status,  race,
occupation,  cohabitation,  homelessness,
having  children,  previous  psychiatric
hospitalisation  and  negative  symptoms  were
the  variables  that  indicated  a  signiﬁcant
association  with  severe  impairment  of  QOL.
Ueoka et  al.,
201135
N  =  61  outpatients
with  schizophrenia
(DSM-IV)
Japan  Longitudinal
study
QLS
BACS
PANSS
CDSS
DIEPSS
Quality  of  life
Cognitive  function
To  analyse  the
association
between  clinical
factors,  especially
cognitive
dysfunction,  and
QOL  in
schizophrenia.
The  results  found  that  negative  and  depressive
symptoms  are  important  factors  for  QOL  in
patients  with  schizophrenia.
Moreover,  there  was  a  signiﬁcant  and  positive
correlation  with  the  QLS  and  the  BACS
composite  score,  the  attention  and  speed  of
information  processing  score  and  the  verbal
memory  score.
Moreover,  cognitive  performance  provides  a
determinant  of  QOL.
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Table  2  (Continued)
Author/year  Sample  Country  Methodology  Instruments  Dimensions  evaluated Aim  Results
Rocca  et  al.,
201036
N  =  118  outpatients
with  schizophrenia
(DSM-IV-TR)
Italy  Cross-sectional
study
QLS
GAF
PANSS
FBF
CDSS
Quality  of  life
Global  functioning
Basic  symptoms  (BS)
To  analyse  the
relationship  of  BS
with  objective
symptoms,
functioning  and
QOL  in  a
population  of
outpatients  with
schizophrenia.
The  results  demonstrate  a  signiﬁcant
correlation  with  QOL  and  functional  outcome.
BS showed  a  signiﬁcant  relationship  with  the
depressive  dimension  (p  <  0.001)  and  global
functioning  (p  <  0.05)  and  some  aspects  of
QOL,  QLS-IF  (p  <  0.05).
Perlick et  al.,
200837
N  =  309  outpatients
with  schizophrenia
(DSM-IV
United
States
Longitudinal
study
QLS
PANSS
WCST
TMT
Functional  status
Neurocognitive
factors
To  analyse  the
relationship
between  positive
and  negative
symptoms,  as  well
as  of
neurocognition
with  functional
status  in  patients
with
schizophrenia.
The  PANSS  explained  16%  additional  variance  in
QLS  total  score  after  accounting  for
demographics  and  visit  number.
The neurocognitive  factors  explained  only  4%
additional  variance  beyond  the  effect  of  the
symptoms.
These  results  suggest  that  symptoms  may  pose
an equal  or  greater  impediment  to  functional
capacity  independent  of  neurocognition  in
patients  with  schizophrenia.
Aki et  al.,
200838
N  =  64  outpatients
with  schizophrenia
(DSM-IV)
Japan  Cross-sectional
study
QLS
SQLS
LSP
BPRS
CDSS
Subjective  quality  of
life
Objective  quality  of
life
Life  skills
Symptoms
To  evaluate  the
associations
between
subjective  and
objective  QOL,
levels  of  life  skills
and  clinical
determinants  in
patients  with
schizophrenia.
The  results  showed  that  the  patients’  QOL
could  be  predicted  by  their  life  skills  measured
by a  family  member.
The  results  suggest  that  negative  symptoms
predict  QOL  evaluated  by  the  QLS.  However,
positive  symptoms  did  not  predict  QOL.
The results  suggested  that  active  treatment
for depressive  and  negative  symptoms  might
be recommended  to  improve  schizophrenic
QOL and  life  skills.
Yamauchi et  al.,
200839
N  =  84  schizophrenia
outpatients  (DSM-IV)
Japan  Cross-sectional
study
QLS
SQLS
PANSS
DIEPSS
Subjective  quality  of
life
Objective  quality  of
life
Clinical  variables
Extrapyramidal
symptoms
To  compare  the
association
between  clinical
variables  and
subjective  and
objective  QOL  in
patients  with
schizophrenia.
Cognitive  dysfunction  had  a  better  effect  on
objective  QOL  than  subjective  QOL.
Negative  symptoms  were  negatively  correlated
with  objective  QOL  (evaluated  by  QLS).
BACS (Brief Assessment of Cognition in Schizophrenia); BPRS (Brief Psychiatric Rating Scale); CDSS (Calgary Depression Scale for Schizophrenia); CGI-S (Clinical Global Impression-Severity
Scale); CISS (Coping Inventory for Stressful situations); CVLT (California Verbal Learning Test); DIEPSS (Drug-Induced Extrapyramidal Symptoms Scale); FBF (Frankfurter-Beﬁndlichkeits-
Skala); GAF (Global Assessment of Functioning Scale); LSP (Life Skills Proﬁle); PANSS (Positive and Negative Syndrome Scale); PSP (Personal and Social Performance Scale); RAS (Recovery
Assessment Scale); RSES (Rosenberg Self-Esteem Scale); SANS (Scale for Assessment of Negative Symptoms); SAPS (Scale for Assessment of Positive Symptoms); SCoRS (The Schizophrenia
Cognition Rating Scale); SUMD (Scale for the Assessment of Unawareness of Mental Disorder); TMT (Trail Making Test); WCST (Wisconsin Card Sorting Test).
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mong  schizophrenics  with  more  severe  negative  symp-
oms,  QLS  scores  were  lower  in  those  with  high  cognitive
eﬁcits.  Depressive  symptoms  did  not  inﬂuence  the  QLS
esults.
One  study29 grouped  the  participants  with  schizophrenia
y  performance  levels  assessed  by  QLS,  divided  into  three
roups,  ‘‘Good  QOL’’,  ‘‘moderate  QOL’’  and  ‘‘poor  QOL’’
nd  related  these  three  groups  with  sociodemographic  and
linical  factors,  Including  negative/positive  symptoms  and
epressive  symptoms.  The  authors  concluded  that  the  good
OL  group  had  lower  severity  levels  of  negative  and  depres-
ive  symptoms.
In  another  study,30 which  related  negative  symptoms,
oping  and  insight,  insight  and  coping-social  diversion  were
ound  to  contribute  to  improving  the  quality  of  life  in
atients  with  high  negative  symptoms.
In  another  study,31 the  results  demonstrated  that  for
atients  with  considerable  positive  symptoms,  higher  levels
f  subjective  recovery  were  related  to  better  instrumen-
al  role  functioning  and  intrapsychic  foundational  abilities
valuated  by  the  QLS.
One  of  the  studies32 evaluated  speciﬁc  negative  symp-
oms  (DE  --  affective  ﬂattening  and  alogia;  AA  --  avolition  and
nhedonia)  and  related  them  to  three  QLS  domains  (exclud-
ng  the  IF  domain  which  evaluates  negative  symptoms)  in
rder  to  evaluate  real  world  functioning.  AA  was  found  to
e  the  most  strongly  associated  with  the  level  of  the  QLS
nterpersonal  relations  (p  <  0.001).  The  DE  subdomain  did
ot  appear  to  have  an  impact  on  real-world  functional  per-
ormance  evaluated  by  the  QLS.
One  study33 found  that  there  was  a  negative  relation-
hip  between  disorganisation  and  QOL  in  the  role  functioning
omain  and  the  intrapsychic  functioning  domain.
One  study,34 which  evaluated  the  relationship  between
OL  and  sociodemographic  and  clinical  factors,  obtained
tatistically  signiﬁcant  results  between  QOL  and  negative
ymptoms,  ﬁnding  that  negative  symptoms  inﬂuenced  the
LS  results.  Positive  symptoms  did  not  produce  signiﬁcant
esults.
Another  study  found  that  negative  and  depressive  symp-
oms  are  important  factors  to  QOL,  obtaining  negative  and
igniﬁcant  correlations  between  the  QLS  and  PANSS  and  CDSS
alues.35
The  study36 which  evaluated  the  basic  symptoms  through
he  FBF  demonstrated  a  signiﬁcant  correlation  between
hem  and  the  intrapsychic  functioning  domain.
In  one  study37 that  related  negative  and  positive  symp-
oms  and  neurocognitive  functioning  to  the  functional  level
f  schizophrenics,  PANSS  was  found  to  explain  16%  of  the
ariance  in  the  total  QLS  score.  Neurocognitive  factors
nly  explain  4%,  such  that  it  was  found  that  symptoms
mpair  functional  level  as  much  or  more  than  neurocognitive
eﬁcits.
In  the  study38 which  used  BPRS,  signiﬁcant  results  were
btained  between  total  QLS  and  BPRS  for  negative  symptoms
R2 =  0.329;  ˇ  =  −0.573;  p  <  0.001).
In  another  study,39 negative  symptoms  were  nega-
ively  associated  with  QOL  (  =  −0.535;  p  <  0.001).  There
as  no  signiﬁcant  correlation  between  QOL  and  positive
ymptoms.
q
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iscussion
he  quality  of  life  and  level  of  functioning  are  consid-
red  important  results  in  the  recovery  of  patients  with
chizophrenia,  with  particular  attention  being  paid  to  these
reas  in  recent  years.  Some  studies  have  demonstrated  the
ssociation  of  some  clinical  and  sociodemographic  factors
ith  quality  of  life  and  level  of  functioning.  However,  many
f  the  scales  used  are  not  speciﬁc  to  schizophrenia  and,  in
ddition,  the  application  of  different  assessment  tools  in  the
arious  studies  may  inﬂuence  the  scientiﬁc  evidence.  For
his  reason,  this  review  was  carried  out,  which  evaluated
nly  studies  that  used  the  QLS  as  an  instrument  to  assess
he  quality  of  life/functioning,  comparing  the  results  with
he  symptoms  of  patients  with  schizophrenia.
Analysis  of  the  results  showed  that  most  of  the  stud-
es  found  a  negative  correlation  between  quality  of
ife/functioning  and  the  negative  symptoms  of  schizophre-
ia.  Given  that  negative  symptoms  interfere  in  social
elationships  and  in  leisure  activities  due  to  their  charac-
eristics,  one  would  expect  them  to  interfere  with  quality
f  life  or  functional  level.  One  of  the  studies  went  further
nd  evaluated  speciﬁc  negative  symptoms,  classifying  them
s  DE  (affective  ﬂattening  and  alogia)  and  AA  (avolition  and
nhedonia)  and  comparing  them  with  three  domains  of  the
LS,  reaching  the  conclusion  that  avolition  and  anhedonia
trongly  inﬂuence  the  interpersonal  relations  domains  of  the
LS,  whereas  affective  ﬂattening  and  alogia  did  not  appear
o  have  a  large  impact  on  QLS  results.32 Given  that  avolition
s  concerned  with  a  lack  of  will  and  anhedonia  with  a  lack  of
leasure  in  activities,  they  are  understood  to  affect  inter-
ersonal  relationships,  as  they  encourage  the  patient  to  stay
t  home,  leading  to  isolation.  One  study  also  concluded  that
egative  symptoms  inﬂuence  the  quality  of  life  regardless  of
ognitive  deﬁcits.28
With  regard  to  positive  symptoms  in  schizophrenia,  in
ne  study29 disorganisation  had  a  negative  relationship  with
uality  of  life  in  two  domains:  the  role  functioning  and  the
ntrapsychic  functioning.  In  another  study,37 positive  symp-
oms  negatively  inﬂuence  the  QLS  total  score  and  all  of
he  subscales.  However,  in  another  study,36 positive  symp-
oms  were  associated  only  with  the  psychosocial  functioning
omain  of  the  QLS.  We  found  that,  regarding  the  inﬂuence
f  positive  symptoms  on  QLS,  the  results  are  not  similar,  so
hat  we  cannot  consider  that  positive  symptoms  inﬂuence
he  quality  of  life.
As  far  as  depressive  symptoms  are  concerned,  two
tudies  showed  that  they  negatively  inﬂuence  quality
f  life/functioning  in  patients  with  schizophrenia.29,35
owever,  the  remaining  studies  that  studied  depressive
ymptoms  found  no  correlation  between  these  and  the
LS.28,30,36,38
Finally,  the  study  that  evaluated  the  basic  symptoms
emonstrated  a  signiﬁcant  correlation  between  these  and
he  intrapsychic  functioning  domain  of  the  QLS.36
In  addition  to  these  results,  one  study30 found  that  in
 group  of  patients  with  severe  negative  symptoms,  those
ith  better  insight  and  coping  strategies  had  a  better
uality  of  life.  Another  study31 found  that  among  patients
ith  more  positive  symptoms,  those  with  better  levels  of
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subjective  recovery  performed  better  on  the  QLS  instrumen-
tal  role  functioning  and  intrapsychic  foundational  domains.
These  results  suggest  that  symptomatology  inﬂuences  the
quality  of  life,  especially  negative  symptoms.  For  this  rea-
son,  we  consider  it  very  important  that  interventions  for
patients  with  schizophrenia  do  not  just  focus  on  decreasing
positive  symptoms,  but  also  on  reducing  negative  symptoms.
Summary  of  methodological  limitations
The  methodology  for  inclusion  and  exclusion  criteria  of  the
systematic  reviews  always  restricted  the  results  obtained
and  can  leave  out  several  important  studies.  In  this  study,
one  inclusion  criterion  was  studied  that  used  the  QLS.  This
fact  excluded  numerous  studies  that  used  other  scales.  How-
ever,  we  consider  it  very  important  to  conduct  a  study  that
only  used  one  scale  to  measure  the  same  construct  because
the  existing  scales  are  very  different  and  comparing  the
results  would  not  be  very  reliable.  Thus,  with  these  criteria,
we  believe  our  study  allowed  us  to  make  a  more  accurate
and  judicious  comparison  of  the  variables  identiﬁed.
There  was  one  limitation  we  found  in  the  articles  ana-
lysed:  small  samples.28,31,34,35,38
Implications for practice
Schizophrenia  is  a  severe  mental  health  disorder  with  serious
challenges  to  quality  of  life/functioning.  Thus,  this  disease  is
surely  a  considerable  problem  in  health  sciences.  Moreover,
the  mechanisms  of  this  mental  health  condition  are  still  far
from  being  elucidated  and  more  studies  should  be  conducted
to  better  understand  this  disease.
Nowadays,  there  is  no  systematic  literature  review  that
provides  a  meta-analysis  into  the  quality  of  life/functioning
in  patients  with  schizophrenia  evaluated  by  the  QLS  and
the  association  with  symptomatology.  The  aim  of  this  study
was  to  ascertain  what  has  been  done  and  to  accentuate  the
importance  of  carrying  out  future  research.
This  research  suggests  new  and  more  longitudinal  studies
are  necessary  and  that  it  is  important  to  extend  these  studies
to  other  countries.
Conclusion
This  review  has  identiﬁed  common  concerns  reported  in  dif-
ferent  studies.
The  studies  analysed,  therefore,  suggest  that  the  qual-
ity  of  life/functioning  in  patients  with  schizophrenia  can
be  inﬂuenced  by  symptomatology  (negative,  positive  and
depressive  symptoms).  As  regards  negative  symptoms  the
studies  appear  to  be  consistent.  Nevertheless,  in  with
regards  to  positive  and  depressive  symptoms,  the  results  are
not  congruent  or  consistent.
We can  thus  conclude  that  the  results  of  the  studies
analysed  demonstrate  that  the  negative  symptoms  inﬂuence
the  quality  of  life  of  patients  with  schizophrenia.  However,
several  other  studies  do  not  offer  conclusive  evidence
as  to  whether  it  is  possible  to  obtain  a  comprehensive
understanding  regarding  other  symptoms  inﬂuencing  the
quality  of  life  of  patients  with  schizophrenia,  owing  to  poor
1nts  9
amples,  lack  of  generalisability  and  the  heterogeneity  of
hese  investigations.
This  literature  review  indicated  that  more  research  is
eeded  to  ﬁnd  better  evidence  as  to  the  symptoms  that
nﬂuence  the  quality  of  life  in  patients  with  schizophrenia.
It  is  also  suggested  that  a  systematic  review  of  the  liter-
ture  should  be  performed  to  evaluate  the  strategies  used
n  psychosocial  rehabilitation  and  its  effectiveness  in  reduc-
ng  the  negative  symptoms  of  patients  with  schizophrenia
onsequently  improving  the  quality  of  life/functioning.
unding
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